METHYLPHENIDATE and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS

1,133 reports of this reaction

1.8% of all METHYLPHENIDATE reports

#10 most reported adverse reaction

Overview

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is the #10 most commonly reported adverse reaction for METHYLPHENIDATE, manufactured by Noven Therapeutics, LLC. There are 1,133 FDA adverse event reports linking METHYLPHENIDATE to WRONG TECHNIQUE IN PRODUCT USAGE PROCESS. This represents approximately 1.8% of all 63,290 adverse event reports for this drug.

Patients taking METHYLPHENIDATE who experience wrong technique in product usage process should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS1,133 of 63,290 reports

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is a less commonly reported adverse event for METHYLPHENIDATE, but still significant enough to appear in the safety profile.

Other Side Effects of METHYLPHENIDATE

In addition to wrong technique in product usage process, the following adverse reactions have been reported for METHYLPHENIDATE:

NO ADVERSE EVENT — 6,875 reports
OFF LABEL USE — 5,881 reports
PRODUCT QUALITY ISSUE — 5,241 reports
DRUG INEFFECTIVE — 2,873 reports
DRUG ADMINISTRATION ERROR — 1,901 reports
WRONG TECHNIQUE IN DRUG USAGE PROCESS — 1,772 reports
APPLICATION SITE ERYTHEMA — 1,684 reports
DRUG DOSE OMISSION — 1,478 reports
INCORRECT DRUG ADMINISTRATION DURATION — 1,191 reports
DRUG PRESCRIBING ERROR — 1,079 reports

Other Drugs Associated with WRONG TECHNIQUE IN PRODUCT USAGE PROCESS

The following drugs have also been linked to wrong technique in product usage process in FDA adverse event reports:

ACETAMINOPHEN, ASPIRIN, CAFFEINE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ALBUTEROL SULFATE BIMATOPROST BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE BUPRENORPHINE AND NALOXONE BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE CARBAMIDE PEROXIDE 6.5%CENEGERMIN BKBJ DOCOSANOL ERENUMAB AOOE ESTRADIOL EVOLOCUMAB FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE GLYCERIN, LIDOCAINE GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE INSULIN HUMAN LEUPROLIDE ACETATE MINOXIDIL NICOTINE

Frequently Asked Questions

Does METHYLPHENIDATE cause WRONG TECHNIQUE IN PRODUCT USAGE PROCESS?

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS has been reported as an adverse event in 1,133 FDA reports for METHYLPHENIDATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is WRONG TECHNIQUE IN PRODUCT USAGE PROCESS with METHYLPHENIDATE?

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS accounts for approximately 1.8% of all adverse event reports for METHYLPHENIDATE, making it a notable side effect.

What should I do if I experience WRONG TECHNIQUE IN PRODUCT USAGE PROCESS while taking METHYLPHENIDATE?

If you experience wrong technique in product usage process while taking METHYLPHENIDATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

METHYLPHENIDATE Full Profile All Drugs Causing WRONG TECHNIQUE IN PRODUCT USAGE PROCESS Noven Therapeutics, LLC Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.